649
Views
11
CrossRef citations to date
0
Altmetric
Review

Structural vaccinology of malaria transmission-blocking vaccines

&
Pages 199-214 | Received 02 Sep 2020, Accepted 16 Dec 2020, Published online: 19 Jan 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Michael F. Good & Danielle I. Stanisic. (2021) Biological strategies and political hurdles in developing malaria vaccines. Expert Review of Vaccines 20:2, pages 93-95.
Read now

Articles from other publishers (10)

Nichole D. Salinas, Rui Ma, Thayne H. Dickey, Holly McAleese, Tarik Ouahes, Carole A. Long, Kazutoyo Miura, Lynn E. Lambert & Niraj H. Tolia. (2023) A potent and durable malaria transmission-blocking vaccine designed from a single-component 60-copy Pfs230D1 nanoparticle. npj Vaccines 8:1.
Crossref
Niharika Shukla, Wai Kwan Tang, Camila H. Coelho, Carole A. Long, Sara A. Healy, Issaka Sagara, Kazutoyo Miura, Patrick E. Duffy & Niraj H. Tolia. (2023) A human antibody epitope map of the malaria vaccine antigen Pfs25. npj Vaccines 8:1.
Crossref
Ada da Silva Matos, Isabela Ferreira Soares, Barbara de Oliveira Baptista, Hugo Amorim dos Santos de Souza, Lana Bitencourt Chaves, Daiana de Souza Perce-da-Silva, Evelyn Kety Pratt Riccio, Letusa Albrecht, Paulo Renato Rivas Totino, Rodrigo Nunes Rodrigues-da-Silva, Cláudio Tadeu Daniel-Ribeiro, Lilian Rose Pratt-Riccio & Josué da Costa Lima-Junior. (2023) Construction, Expression, and Evaluation of the Naturally Acquired Humoral Immune Response against Plasmodium vivax RMC-1, a Multistage Chimeric Protein. International Journal of Molecular Sciences 24:14, pages 11571.
Crossref
Thayne H. Dickey, Richi Gupta, Holly McAleese, Tarik Ouahes, Sachy Orr-Gonzalez, Rui Ma, Olga Muratova, Nichole D. Salinas, Jen C. C. Hume, Lynn E. Lambert, Patrick E. Duffy & Niraj H. Tolia. (2023) Design of a stabilized non-glycosylated Pfs48/45 antigen enables a potent malaria transmission-blocking nanoparticle vaccine. npj Vaccines 8:1.
Crossref
Wai Kwan Tang, Camila H. Coelho, Kazutoyo Miura, Bergeline C. Nguemwo Tentokam, Nichole D. Salinas, David L. Narum, Sara A. Healy, Issaka Sagara, Carole A. Long, Patrick E. Duffy & Niraj H. Tolia. (2023) A human antibody epitope map of Pfs230D1 derived from analysis of individuals vaccinated with a malaria transmission-blocking vaccine. Immunity 56:2, pages 433-443.e5.
Crossref
Marjan Talebi, Saeed Samarghandian, Tahereh Farkhondeh & Mohsen Talebi. 2023. Natural Products in Vector-Borne Disease Management. Natural Products in Vector-Borne Disease Management 201 221 .
Niharika Shukla, Wai Kwan Tang & Niraj H. Tolia. (2022) Structural analysis of Plasmodium falciparum ookinete surface antigen Pfs28 relevant for malaria vaccine design. Scientific Reports 12:1.
Crossref
Frankie M. T. Lyons, Mikha Gabriela, Wai-Hong Tham & Melanie H. Dietrich. (2022) Plasmodium 6-Cysteine Proteins: Functional Diversity, Transmission-Blocking Antibodies and Structural Scaffolds. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Maya Aleshnick, Melina Florez-Cuadros, Thomas Martinson & Brandon K. Wilder. (2022) Monoclonal antibodies for malaria prevention. Molecular Therapy 30:5, pages 1810-1821.
Crossref
Eizo Takashima, Mayumi Tachibana, Masayuki Morita, Hikaru Nagaoka, Bernard N. Kanoi & Takafumi Tsuboi. (2021) Identification of Novel Malaria Transmission-Blocking Vaccine Candidates. Frontiers in Cellular and Infection Microbiology 11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.